Veterinary medicinal product register

The FVS registers website is using cookies. By continuing using this website you are agreeing to use cookies. Agree Cookies policy
Data selected by 946 Name ficoxil
Original name Strength Marketing authorisation number Marketing authorisation holder: ATCvet code Species More
Ficoxil 57 mg V/DCP/21/0047 Industrial Veterinaria, S.A., Spānija QM01AH90 dogs Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Firocoxib
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [DOCX] 23102025LI (23-Oct-2025)
Labelling text: [DOCX] 23102025M (23-Oct-2025)
Summary of product characteristics: [DOCX] 23102025ZA (23-Oct-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/21/0047-01 57 mg 1 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/21/0047-02 57 mg 3 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/21/0047-03 57 mg 6 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/21/0047-04 57 mg 10 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/21/0047-05 57 mg 18 PVDH/PE/PVH/Al blisteris, 10 tablete -
Ficoxil 227 mg V/DCP/21/0048 Industrial Veterinaria, S.A., Spānija QM01AH90 dogs Vairāk

Medicinal product information

Pharmaceutical form: chewable tablets
International name (active substance): Firocoxib
Distribution category: To be supplied only on veterinary prescription
Manufacturer(s) responsible for batch release Lelypharma B.V., Nīderlande
Date of authorisation/renewal: 28-Jan-2022
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: DCP
Package leaflet: [DOCX] 23102025LI (23-Oct-2025)
Labelling text: [DOCX] 23102025M (23-Oct-2025)
Summary of product characteristics: [DOCX] 23102025ZA (23-Oct-2025)

Products

ID Strength Package size Primary packaging Labelling
V/DCP/21/0048-01 227 mg 1 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/21/0048-02 227 mg 3 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/21/0048-03 227 mg 6 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/21/0048-04 227 mg 10 PVDH/PE/PVH/Al blisteris, 10 tablete -
V/DCP/21/0048-05 227 mg 18 PVDH/PE/PVH/Al blisteris, 10 tablete -

2 records · Download

  • 1